chartexchange

Elutia Inc (ELUT) Q3 2026 Earnings Call Highlights: Cardiovascular Growth and NXT-41X Momentum ...

GuruFocus | Nov 6, 2026 12:21 AM EST

Elutia Inc (ELUT) posted 20% sales growth and raised $26 million without an equity offering, while advancing its infection-fighting NXT-41X toward a Q2 2027 clearance decision. Related Stocks: ELUT ,

Read original article